Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Cancer Chemotherapy and Pharmacology
|
September 18, 2009
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series
Liliana Montella, Raffaele Addeo, Giovannella Palmieri, et al.
Oncology Reports
|
March 29, 2007
Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors
Raffaele Addeo, Stefania Crisci, Velia D'Angelo, et al.
Cancer Biology & Therapy
|
June 14, 2013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
Cirino Botta, Vito Barbieri, Domenico Ciliberto, et al.
Cancer Biology & Therapy
|
August 11, 2010
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients
Pierpaolo Correale, Cinzia Remondo, Salvatore Francesco Carbone, et al.
Molecular and Clinical Oncology
|
February 10, 2023
Clinical activity of regorafenib in elderly patients with recurrent glioblastoma
Morena Fasano, Mario Pirozzi, Vincenzo Famiglietti, et al.
Journal of Translational Medicine
|
October 15, 2024
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation
Piera Grisolia, Rossella Tufano, Clara Iannarone, et al.
Cancer Biology & Therapy
|
April 29, 2011
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
Pierpaolo Correale, Cirino Botta, Assunta Basile, et al.
Oncology Letters
|
April 30, 2017
Locally advanced paranasal sinus carcinoma: A study of 30 patients
Francesco Perri, Raffaele Addeo, Manuel Conson, et al.
Frontiers in Oncology
|
May 21, 2025
Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
Marianna Caterino, Giorgio Lo Giudice, Vincenzo Damiano, et al.
International Journal of Molecular Sciences
|
July 29, 2025
The First Case Report of a Solitary Pulmonary Metastasis of a Transitional Meningioma and Literature Review
Sara Di Lorenzo, Stefano Farese, Ciro Balbo, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Cancer Chemotherapy and Pharmacology
|
September 18, 2009
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series
Liliana Montella, Raffaele Addeo, Giovannella Palmieri, et al.
Oncology Reports
|
March 29, 2007
Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors
Raffaele Addeo, Stefania Crisci, Velia D'Angelo, et al.
Cancer Biology & Therapy
|
June 14, 2013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
Cirino Botta, Vito Barbieri, Domenico Ciliberto, et al.
Cancer Biology & Therapy
|
August 11, 2010
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients
Pierpaolo Correale, Cinzia Remondo, Salvatore Francesco Carbone, et al.
Molecular and Clinical Oncology
|
February 10, 2023
Clinical activity of regorafenib in elderly patients with recurrent glioblastoma
Morena Fasano, Mario Pirozzi, Vincenzo Famiglietti, et al.
Journal of Translational Medicine
|
October 15, 2024
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation
Piera Grisolia, Rossella Tufano, Clara Iannarone, et al.
Cancer Biology & Therapy
|
April 29, 2011
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
Pierpaolo Correale, Cirino Botta, Assunta Basile, et al.
Oncology Letters
|
April 30, 2017
Locally advanced paranasal sinus carcinoma: A study of 30 patients
Francesco Perri, Raffaele Addeo, Manuel Conson, et al.
Frontiers in Oncology
|
May 21, 2025
Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
Marianna Caterino, Giorgio Lo Giudice, Vincenzo Damiano, et al.
International Journal of Molecular Sciences
|
July 29, 2025
The First Case Report of a Solitary Pulmonary Metastasis of a Transitional Meningioma and Literature Review
Sara Di Lorenzo, Stefano Farese, Ciro Balbo, et al.
Page
of 11